These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12164939)

  • 61. [Combination of etretinate and dithrocream for severe psoriasis].
    Vardy D; Werner E
    Harefuah; 1988 Apr; 114(7):342-4. PubMed ID: 3371786
    [No Abstract]   [Full Text] [Related]  

  • 62. [Current treatment of psoriasis].
    Frenk E
    Rev Med Suisse Romande; 1989 Jun; 109(6):437-41. PubMed ID: 2756270
    [No Abstract]   [Full Text] [Related]  

  • 63. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
    Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
    Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis.
    Saihan EM; Albano J; Burton JL
    Br J Dermatol; 1980 May; 102(5):565-9. PubMed ID: 6248098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
    Sprecher E; Bergman R; Friedman-Birnbaum R
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):197-8. PubMed ID: 10343966
    [No Abstract]   [Full Text] [Related]  

  • 66. Psoriasis. A review of recent advances in treatment.
    Farber EM; Nall L
    Drugs; 1984 Oct; 28(4):324-46. PubMed ID: 6386427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study.
    Takano-Kawasaki S; Sato E; Yamaguchi K; Imafuku S
    J Dermatol; 2023 Jan; 50(1):82-88. PubMed ID: 36229921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
    Baran A; Swiderska M; Flisiak I
    J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluorescent photoaffinity labeling: adenosine 3',5'-cyclic monophosphate receptor sites.
    Dreyfuss G; Schwartz K; Blout ER; Barrio JR; Liu FT; Leonard NJ
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1199-203. PubMed ID: 206888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New indications and new retinoids.
    Gollnick H
    Dermatologica; 1987; 175 Suppl 1():182-95. PubMed ID: 3319725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes.
    Gottlieb S; Hayes E; Gilleaudeau P; Cardinale I; Gottlieb AB; Krueger JG
    J Cutan Pathol; 1996 Oct; 23(5):404-18. PubMed ID: 8915849
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
    Baran A; Świderska M; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis.
    Shiohara T; Imanishi K; Sagawa Y; Nagashima M
    J Am Acad Dermatol; 1992 Oct; 27(4):568-74. PubMed ID: 1401309
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The labeling with 8-azido-cyclic adenosine monophosphate of proteins in vesicles of sarcoplasmic reticulum from rabbit skeletal muscle.
    Lord ST; Richards FM
    Biochim Biophys Acta; 1981 Nov; 649(1):13-23. PubMed ID: 6272856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments.
    Danno K; Kaji A; Mochizuki T
    J Dermatol Sci; 1996 Oct; 13(1):49-55. PubMed ID: 8902653
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
    Painsi C; Patscheider M; Inzinger M; Lange-Asschenfeldt B; Quehenberger F; Wolf P
    J Dtsch Dermatol Ges; 2015 Nov; 13(11):1156-63. PubMed ID: 26513076
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo study of skin mechanical properties in psoriasis vulgaris.
    Dobrev H
    Acta Derm Venereol; 2000; 80(4):263-6. PubMed ID: 11028858
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cutaneous vasculitis in psoriasis.
    Wong SS; Marks R
    Acta Derm Venereol; 1994 Jan; 74(1):57-60. PubMed ID: 7908486
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A.
    Dalaker M; Jacobsen T; Lysvand H; Iversen OJ
    Acta Derm Venereol; 1999 Jul; 79(4):281-4. PubMed ID: 10429984
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Altered erythrocyte membrane phosphorylation in psoriasis.
    Kumar R; Weiss VC; West DP; Chiero LA
    Br J Dermatol; 1983 Sep; 109(3):267-75. PubMed ID: 6311238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.